Chemicals and pharmaceuticals · NVAX

NOVAVAX INC

12 filings mentioning 9 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
9topics disclosed
Chemicals and pharmaceuticalsindustry
MDbased in

Across 12 filings we hold, NOVAVAX INC has written down 9 of the topics we track. That places it 120 of 222 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

NVAX Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something NOVAVAX INC has written into a filing. Not what they said. What applies once they have said it.

NIST Cybersecurity Framework 2.078
ISO/IEC 42001:202361
ISO 27001:202242
NIST AI Risk Management Framework (AI RMF 1.0)41
ISO 37001:201639
ISO 22301:201938
ASD Strategies to Mitigate Cyber Security Incidents29
ISO 3700126
Colorado Artificial Intelligence Act (proposed SB 24-205)16
EU AI Act15

10 frameworks, 385 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Restatement14
Internal Control8
Business Continuity2
Ransomware2
Artificial Intelligence2
Consent Order2
Regulatory Investigation1
Audit Committee Oversight1
Regulatory Reporting1

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Restatement142026-06-23
Internal Control82024-05-13
Business Continuity22022-11-09
Ransomware22023-02-28
Artificial Intelligence22025-03-11
Consent Order22025-08-27
Regulatory Investigation12022-12-19
Audit Committee Oversight12026-02-26
Regulatory Reporting12026-02-26

When it filed

Filings we hold, by year. Hover a bar for the count.

20
21
22
23
24
25
26

Recent filings

FiledFormItem
2026-06-238-KShareholder votefiling
2026-02-2610-Kfiling
2025-10-228-KEntry into a material agreement, Material impairment, Other material eventfiling
2025-08-278-KEntry into a material agreement, Item 2.03, Item 3.02filing
2025-03-118-KDirector or officer departure, Regulation FD disclosure, Financial statements and exhibitsfiling
2025-02-278-KResults of operations, the earnings release, Financial statements and exhibitsfiling
2024-06-148-KDirector or officer departure, Shareholder vote, Financial statements and exhibitsfiling
2024-05-138-KEntry into a material agreement, Item 3.02, Financial statements and exhibitsfiling
2023-08-088-KEntry into a material agreement, Item 1.02, Item 3.02filing
2023-08-088-KOther material event, Financial statements and exhibitsfiling
2023-07-118-KDirector or officer departure, Shareholder vote, Financial statements and exhibitsfiling
2023-02-2810-Kfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
AIMHEMISPHERX BIOPHARMA INC12compare →
WINTWINDTREE THERAPEUTICS INC /DE/12compare →
BCDABioCardia, Inc.12compare →
ARMPArmata Pharmaceuticals, Inc.12compare →
NBIXNEUROCRINE BIOSCIENCES INC12compare →
TTNPTITAN PHARMACEUTICALS INC12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition